TXG
10x Genomics, Inc.
Latest Form 4:Sale$668KbySaxonov Serge (Chief Executive Officer) · filed Aug 28, 2026
10x Genomics, Inc. (TXG) has 31 SEC Form 4 filings (44 transaction rows) in the rolling window, disclosed by 6 distinct insiders. Most recent filing: Aug 28, 2026.
The most active filer is Chief Executive Officer Saxonov Serge with 10 filings. Insiders have net sold $8.9M over the trailing 6 months.
- Industry:Medical - Healthcare Information Services
- CEO:Serge Saxonov
- Employees:1,178
- HQ:Pleasanton, CA, US
- IPO:2019-09-12
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$9.7M
reported sales (SEC code S)
Unique Insiders
6
in the rolling window
Market Cap
$8.1B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
| Chief Executive Officer | Sale | 10,486 | $668K | Aug 28 | SEC ↗ | |
| Director | Sale | 2,207 | $140K | Aug 26 | SEC ↗ | |
Taich AdamFirst in 3 months | Chief Financial Officer | Sale | 17,166 | $1.1M | Aug 26 | SEC ↗ |
Hindson Benjamin J.First in 3 months | See Remarks | Sale | 13,818 | $871K | Aug 26 | SEC ↗ |
| Chief Executive Officer | Sale | 18,545 | $1.2M | Aug 26 | SEC ↗ | |
Teichmann Sarah A.First filing | Director | Sale | 5,278 | $302K | Aug 17 | SEC ↗ |
Teichmann Sarah A.First filing | Director | Sale | 2,273 | $130K | Aug 17 | SEC ↗ |
STUELPNAGEL JOHN RFirst filing | Director | Sale | 20,000 | $1.2M | Aug 13 | SEC ↗ |
| Chief Executive Officer | Sale | 30,000 | $1.0M | Jun 24 | SEC ↗ | |
| Director | Sale | 5,723 | $187K | Jun 18 | SEC ↗ | |
| Chief Executive Officer | Sale | 18,175 | $444K | May 27 | SEC ↗ | |
| Chief Executive Officer | Sale | 10,718 | $265K | May 27 | SEC ↗ | |
Hindson Benjamin J.First in 3 months | See Remarks | Sale | 11,595 | $283K | May 27 | SEC ↗ |
Taich AdamFirst in 6 months | Chief Financial Officer | Sale | 15,098 | $369K | May 27 | SEC ↗ |
| Chief Executive Officer | Sale | 5,000 | $123K | Apr 16 | SEC ↗ | |
| Chief Executive Officer | Sale | 10,000 | $191K | Mar 25 | SEC ↗ | |
| Chief Executive Officer | Sale | 5,000 | $98K | Mar 25 | SEC ↗ | |
Saxonov SergeFirst in 3 months | Chief Executive Officer | Sale | 16,152 | $367K | Mar 4 | SEC ↗ |
Hindson Benjamin J.First in 3 months | See Remarks | Sale | 7,826 | $145K | Feb 25 | SEC ↗ |
Hindson Benjamin J.First filing | See Remarks | Sale | 8,283 | $157K | Nov 25 | SEC ↗ |
Saxonov SergeFirst filing | Chief Executive Officer | Sale | 13,261 | $252K | Nov 25 | SEC ↗ |
Taich AdamFirst filing | Chief Financial Officer | Sale | 11,888 | $226K | Nov 25 | SEC ↗ |
Related companies
10x Genomics, Inc. is in the Healthcare sector.